1. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI
- Author
-
Rasoul, S., Ottervanger, J. P., Bilo, H. J. G., Timmer, J. R., van't Hof, A. W. J., Dikkeschei, L. D., Hoorntje, J. C. A., de Boer, M. J., Zijlstra, F., Dambrink, Jan Hendrik Everwijn, Faculteit Medische Wetenschappen/UMCG, and Lifestyle Medicine (LM)
- Subjects
RISK ,MORTALITY ,BLOOD-GLUCOSE ,DIABETES-MELLITUS ,HbAic ,METABOLISM ,ISCHEMIC-MYOCARDIUM ,THROMBOLYTIC ERA ,ST-elevation acute myocardial infarction ,CARDIOVASCULAR-DISEASE ,outcome ,STRESS HYPERGLYCEMIA ,FATTY-ACIDS ,admission glucose - Abstract
Background: Admission hyperglycaemia is associated with an increased risk of mortality after myocardial infarction. Whether long-term glucose dysregulation (assessed by HbAic) is more important than acute hyperglycaemia is unknown. We evaluated the prognostic value of admission glucose and HbAic levels in nondiabetic patients with ST-segment elevation acute myocardial infarction (STEMI). Methods: In 504 unselected, consecutive patients with STEMI, glucose and HbAic levels were measured on admission. Glucose was categorised as = 11.1 mmol/l (n=82). HbAic levels were categorised as = 6.0% (n=88). Mean follow-up was 1.6 +/- 0.6 years. Results: Patients with hyperglycaemia on admission were comparable with those with normoglycaernia. However, patients with HbAic >= 6.0%, as compared with those with HbAic = 11.1 mmol/l) was 4% and 19% (p= 6%) was 5% and 12% (p=0.03)After multivariable analyses, admission glucose (OR 4.91, 95% CI 2.03 to 11.9, p
- Published
- 2007